$VREX 4/A SEC Filings

Filed On	Filing
13 Jan 2021	Form 4/A: Guertin Timothy E, Director Granted 4,840 Deferred Stock Units
24 Feb 2017	Form 4/A: Verhoef Clarence R, SVP & Chief Financial Officer Granted 19,332 Non-Qualified Stock Option (right to buy)
24 Feb 2017	Form 4/A: Sanyal Sunny, Director Granted 81,610 Non-Qualified Stock Option (right to buy)
09 Feb 2017	Form 4/A: Colbeth Richard E., SVP and GM, X-Ray Detectors Granted 40,150 Non-Qualified Stock Option (right to buy) · Granted 10,447 Restricted Stock Units
09 Feb 2017	Form 4/A: Jonaitis Mark S., SVP and GM, X-Ray Sources Granted 83,739 Non-Qualified Stock Option (right to buy) · Granted 14,953 Restricted Stock Units
09 Feb 2017	Form 4/A: LaCasce Carl E., SVP, Sales & Marketing Granted 83,739 Non-Qualified Stock Option (right to buy) · Granted 14,953 Restricted Stock Units
09 Feb 2017	Form 4/A: Verhoef Clarence R, SVP & Chief Financial Officer Granted 118,012 Non-Qualified Stock Option (right to buy) · Granted 13,830 Restricted Stock Units
09 Feb 2017	Form 4/A: Sanyal Sunny, Director Granted 312,113 Non-Qualified Stock Option (right to buy) · Granted 23,492 Restricted Stock Units
09 Feb 2017	Form 4/A: Reinhardt Erich R, Director Granted 15,074 Non-Qualified Stock Option (right to buy) · Granted 17,329 Deferred Stock Units
09 Feb 2017	Form 4/A: Naumann-etienne Ruediger, Director Granted 17,329 Deferred Stock Units
09 Feb 2017	Form 4/A: Honeysett Kimberley E., SVP and General Counsel Granted 9,189 Non-Qualified Stock Option (right to buy) · Granted 7,286 Restricted Stock Units

Comments